LAMICTAL        SUPPORTING DATA 
Prevents depression
Does not destabilize mood
Improves quality of life
Tolerability similar to placebo
No weight gain
13 years of experience
A new approach
Introduce at any phase
Can be used in combination
Supporting data
Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer
print this page
 Pharmacokinetics of lithium and lamotrigine*

Authors: Chen C, et al. 
Title: The effects of lamotrigine on the pharmacokinetics of lithium. 
Reference: Br J Clin Pharmacol 2000;50:193-5. 
Purpose: To determine whether lamotrigine affects lithium pharmacokinetics. 
Study design: Open-label, randomized, cross-over study. 
Follow up: 6 days. 
Patients: 20 healthy adult men. 
Treatment:
Lithium 2g every 12 hours with or without lamotrigine 100 mg once daily.
Results: Lamotrigine did not cause a significant change in the pharmacokinetics of lithium. Key pharmacokinetic parameters for lithium varied by 10% or less with and without combination lamotrigine treatment.

*Sponsored by GSK



 
 


 
home help sitemap acronyms help sitemap home